Clinical trial
Strategies to Reduce Organic Muscle Atrophy in the Intensive Care Unit (STROMA-ICU)
NCT02773771 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Strategies to Reduce Organic Muscle Atrophy in the Intensive Care Unit (STROMA-ICU)
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- January 31, 2017
- Completion date
- January 31, 2019
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
muscle atrophy